Etrasimod
ATC L04AE05 · 7 markets · 7 records
GB 1 records · 1 strengths
- 2 mgtabletVelsipity
CA 1 records · 1 strengths
- 2 mgtabletVelsipity
AU 1 records · 1 strengths
- 2 mgtabletVelsipity
SG 1 records · 1 strengths
- 2 mgtabletVelsipity
ES 1 records · 1 strengths
- 2 mgtabletVelsipity
HK 1 records · 1 strengths
Records without a stated strength · 1 Velsipity
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Velsipity
| Strength / form / release | GB | CA | AU | SG | ES | HK | EU |
|---|---|---|---|---|---|---|---|
| 2 mg tablet | Velsipity | Velsipity | Velsipity | Velsipity | Velsipity | ||
unknown | Velsipity | Velsipity |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in HK · EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en HK · EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 HK · EU 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 HK · EU 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.